Comparison of medical treatment with percutaneous closure of patent foramen ovale in patients with cryptogenic stroke

S Windecker, A Wahl, K Nedeltchev, M Arnold… - Journal of the American …, 2004 - jacc.org
Objectives: The purpose of this study was to compare the efficacy of medical treatment with
percutaneous closure of patent foramen ovale (PFO). Background: Patients with cryptogenic …

Patent foramen ovale: a comprehensive review

MK Teshome, K Najib, CC Nwagbara… - Current problems in …, 2020 - Elsevier
Foramen ovale is an embryonic defect in the interatrial septum which allows passage of
oxygenated blood from the right atrium to the left atrium. 1, 2 In about 75% of the population …

Patent foramen ovale closure or antiplatelet therapy for cryptogenic stroke

L Søndergaard, SE Kasner, JF Rhodes… - … England Journal of …, 2017 - Mass Medical Soc
Background The efficacy of closure of a patent foramen ovale (PFO) in the prevention of
recurrent stroke after cryptogenic stroke is uncertain. We investigated the effect of PFO …

Transcatheter closure of patent foramen ovale in patients with cerebral ischemia

MU Braun, D Fassbender, SP Schoen, M Haass… - Journal of the American …, 2002 - jacc.org
Objectives: The present study was conducted to determine the safety of the transcatheter
closure of a patent foramen ovale (PFO) in patients with cryptogenic cerebral ischemia and …

Device closure versus medical therapy alone for patent foramen ovale in patients with cryptogenic stroke: a systematic review and meta-analysis

R Shah, M Nayyar, IS Jovin, A Rashid… - Annals of internal …, 2018 - acpjournals.org
This article has been corrected. The original version (PDF) is appended to this article as a
Supplement. Background: The optimal strategy for preventing recurrent stroke in patients …

Device closure of patent foramen ovale after stroke: pooled analysis of completed randomized trials

DM Kent, IJ Dahabreh, R Ruthazer, AJ Furlan… - Journal of the American …, 2016 - jacc.org
Background The comparative effectiveness of percutaneous closure of patent foramen ovale
(PFO) plus medical therapy versus medical therapy alone for cryptogenic stroke is uncertain …

Cryptogenic stroke and patent foramen ovale

MK Mojadidi, MO Zaman, IY Elgendy… - Journal of the American …, 2018 - jacc.org
Nearly one-half of patients with cryptogenic stroke have a patent foramen ovale (PFO). The
dilemma of whether to close these PFOs percutaneously, in an effort to reduce the risk of …

Stroke prevention by percutaneous closure of patent foramen ovale: a systematic review and meta-analysis

M Wolfrum, GM Froehlich, G Knapp, LK Casaubon… - Heart, 2014 - heart.bmj.com
Context The role of percutaneous closure of patent foramen oval (PFO) in patients with
cryptogenic stroke has been very controversial for years due to a lack of clear evidence …

Cryptogenic stroke and high-risk patent foramen ovale: the DEFENSE-PFO trial

PH Lee, JK Song, JS Kim, R Heo, S Lee, DH Kim… - Journal of the American …, 2018 - jacc.org
Background: Recent reports showing the favorable role of patent foramen ovale (PFO)
closure in patients with cryptogenic stroke have raised the issue of selecting optimal …

Patent foramen ovale transcatheter closure vs. medical therapy on recurrent vascular events: a systematic review and meta-analysis of randomized controlled trials

P Rengifo-Moreno, IF Palacios… - European heart …, 2013 - academic.oup.com
Background In patients with cryptogenic stroke, transcatheter (TC) closure of a patent
foramen ovale (PFO) has not been shown to better prevent recurrent vascular events than …